Cures, tuberculosis, and deterritorialized biomedical narratives

Paul Howard Mason, Greg J. Fox, Jennifer Ho, Chris Degeling

Research output: Contribution to journalArticleOtherpeer-review

2 Citations (Scopus)

Abstract

In the essay “Cures” (Public Culture, September 2016), Bharat Venkat examines how biomedical scientists, since the time of Robert Koch (1843–1910), have contested what counts as trustworthy evidence of a cure for tuberculosis. Widespread cultural shifts accompanied these medical debates and developments. Randomized controlled trials now dominate as an evidentiary form in tuberculosis control with implications for how global health efforts roll out across diverse cultural contexts. A pharmaceutical approach drives the international export of a capsular cure to the neglect of providing sanatorium care, addressing disease transmission, and curbing drug resistance. In response to Venkat’s essay, Paul Mason and colleagues highlight how a biomedical narrative about tuberculosis became deterritorialized from high-income countries where new tuberculosis cases were decreasing, and reterritorialized in low-income countries where tuberculosis incidence was increasing. Pharmaceutical models of disease control have proven convincing and popular, but in going global they have had unintended consequences.
Original languageEnglish
Pages (from-to)269-276
Number of pages8
JournalPublic Culture
Volume30
Issue number2
DOIs
Publication statusPublished - 2018

Keywords

  • Tuberculosis (TB)

Cite this

Mason, Paul Howard ; Fox, Greg J. ; Ho, Jennifer ; Degeling, Chris. / Cures, tuberculosis, and deterritorialized biomedical narratives. In: Public Culture. 2018 ; Vol. 30, No. 2. pp. 269-276.
@article{fccb9eede0934090bd174d8c7116b027,
title = "Cures, tuberculosis, and deterritorialized biomedical narratives",
abstract = "In the essay “Cures” (Public Culture, September 2016), Bharat Venkat examines how biomedical scientists, since the time of Robert Koch (1843–1910), have contested what counts as trustworthy evidence of a cure for tuberculosis. Widespread cultural shifts accompanied these medical debates and developments. Randomized controlled trials now dominate as an evidentiary form in tuberculosis control with implications for how global health efforts roll out across diverse cultural contexts. A pharmaceutical approach drives the international export of a capsular cure to the neglect of providing sanatorium care, addressing disease transmission, and curbing drug resistance. In response to Venkat’s essay, Paul Mason and colleagues highlight how a biomedical narrative about tuberculosis became deterritorialized from high-income countries where new tuberculosis cases were decreasing, and reterritorialized in low-income countries where tuberculosis incidence was increasing. Pharmaceutical models of disease control have proven convincing and popular, but in going global they have had unintended consequences.",
keywords = "Tuberculosis (TB)",
author = "Mason, {Paul Howard} and Fox, {Greg J.} and Jennifer Ho and Chris Degeling",
year = "2018",
doi = "123",
language = "English",
volume = "30",
pages = "269--276",
journal = "Public Culture",
issn = "0899-2363",
publisher = "Duke University Press",
number = "2",

}

Cures, tuberculosis, and deterritorialized biomedical narratives. / Mason, Paul Howard; Fox, Greg J.; Ho, Jennifer; Degeling, Chris.

In: Public Culture, Vol. 30, No. 2, 2018, p. 269-276.

Research output: Contribution to journalArticleOtherpeer-review

TY - JOUR

T1 - Cures, tuberculosis, and deterritorialized biomedical narratives

AU - Mason, Paul Howard

AU - Fox, Greg J.

AU - Ho, Jennifer

AU - Degeling, Chris

PY - 2018

Y1 - 2018

N2 - In the essay “Cures” (Public Culture, September 2016), Bharat Venkat examines how biomedical scientists, since the time of Robert Koch (1843–1910), have contested what counts as trustworthy evidence of a cure for tuberculosis. Widespread cultural shifts accompanied these medical debates and developments. Randomized controlled trials now dominate as an evidentiary form in tuberculosis control with implications for how global health efforts roll out across diverse cultural contexts. A pharmaceutical approach drives the international export of a capsular cure to the neglect of providing sanatorium care, addressing disease transmission, and curbing drug resistance. In response to Venkat’s essay, Paul Mason and colleagues highlight how a biomedical narrative about tuberculosis became deterritorialized from high-income countries where new tuberculosis cases were decreasing, and reterritorialized in low-income countries where tuberculosis incidence was increasing. Pharmaceutical models of disease control have proven convincing and popular, but in going global they have had unintended consequences.

AB - In the essay “Cures” (Public Culture, September 2016), Bharat Venkat examines how biomedical scientists, since the time of Robert Koch (1843–1910), have contested what counts as trustworthy evidence of a cure for tuberculosis. Widespread cultural shifts accompanied these medical debates and developments. Randomized controlled trials now dominate as an evidentiary form in tuberculosis control with implications for how global health efforts roll out across diverse cultural contexts. A pharmaceutical approach drives the international export of a capsular cure to the neglect of providing sanatorium care, addressing disease transmission, and curbing drug resistance. In response to Venkat’s essay, Paul Mason and colleagues highlight how a biomedical narrative about tuberculosis became deterritorialized from high-income countries where new tuberculosis cases were decreasing, and reterritorialized in low-income countries where tuberculosis incidence was increasing. Pharmaceutical models of disease control have proven convincing and popular, but in going global they have had unintended consequences.

KW - Tuberculosis (TB)

UR - http://www.scopus.com/inward/record.url?scp=85045704234&partnerID=8YFLogxK

U2 - 123

DO - 123

M3 - Article

VL - 30

SP - 269

EP - 276

JO - Public Culture

JF - Public Culture

SN - 0899-2363

IS - 2

ER -